BIOCRYST PHARMACEUTICA
7.5000
27-نوفمبر-24 16:45:00
15 متأخرة بدقائق
الأسهم
+0.0100
+0.13%
نطاق اليوم
7.4250 - 7.6300
ISIN
N/A
المصدر
NASDAQ
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 يوليو 2023 07:00:12 بحسب Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 يونيو 2023 07:00:42 بحسب Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
01 يونيو 2023 07:00:45 بحسب Nasdaq GlobeNewswire
-
31 مايو 2023 07:02:04 بحسب Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Public Health Institute of Chile
22 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 مايو 2023 16:01:01 بحسب Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update
03 مايو 2023 07:00:55 بحسب Nasdaq GlobeNewswire
-
27 أبريل 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2023 Financial Results on May 3
19 أبريل 2023 07:00:27 بحسب Nasdaq GlobeNewswire
-
BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon
18 أبريل 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
12 أبريل 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 أبريل 2023 07:00:36 بحسب Nasdaq GlobeNewswire
-
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
31 مارس 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success
29 مارس 2023 16:01:31 بحسب Nasdaq GlobeNewswire
-
08 مارس 2023 15:00:00 بحسب Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 مارس 2023 07:00:13 بحسب Nasdaq GlobeNewswire
-
24 فبراير 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
22 فبراير 2023 07:00:04 بحسب Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones
21 فبراير 2023 07:00:23 بحسب Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2022 Financial Results on February 21
07 فبراير 2023 07:00:16 بحسب Nasdaq GlobeNewswire